PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Expenses
$25.52M
Quarterly · Period ending: · USD
PHAS Operating Expenses
Latest reported$25.52Mperiod ending
Latest reported$25.52Mperiod ending
PHAS Quarterly Operating Expenses ($1.90M → $25.52M)
Quarterly operating expenses
High-resolution chart · PNG
PHAS operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 25,520,000 | |
| 18,345,000 | |
| -85,830,807 | |
| 28,911,000 | |
| 31,391,000 | |
| 25,647,000 | |
| 25,978,000 | |
| 20,492,000 | |
| 24,098,000 | |
| 14,608,000 | |
| 12,044,000 | |
| 11,831,000 | |
| 10,185,000 | |
| 8,037,000 | |
| 7,917,000 | |
| 5,410,000 | |
| 4,107,000 | |
| 2,878,000 | |
| 2,451,000 | |
| 1,895,000 |